Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Plu-Bureau

Showing results (41-50 of 61) with videos related to

Pageof 7
Sort By:
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 1, 1993
Oral contraceptive use and risk of benign breast disease in a French case-control study of young womenI Charreau, G Plu-Bureau, A Bachelot, et al.
British Journal of Cancer|August 1, 1994
Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast diseaseG Plu-Bureau, M G Lê, R Sitruk-Ware, et al.
Annales De Dermatologie Et De Venereologie|May 1, 2016
Pregnancy and contraception in systemic and cutaneous lupus erythematosusG Guettrot-Imbert, N Morel, V Le Guern, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|May 3, 2017
[Learning the gynecological examination on low-fidelity simulation: Impact on the feelings of medical students]J Hugon-Rodin, C Sonigo, D Drummond, et al.
Thrombosis and Haemostasis|October 18, 1993
Haemostatic variables and menopausal status: influence of hormone replacement therapyP Y Scarabin, G Plu-Bureau, L Bara, et al.
Journal of Thrombosis and Haemostasis : JTH|August 31, 2004
Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptivesM Alhenc-Gelas, G Plu-Bureau, S Guillonneau, et al.
Thrombosis Research|May 9, 2001
Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen usersE Oger, M Alhenc-Gelas, G Plu-Bureau, et al.
Human Reproduction (Oxford, England)|September 20, 2022
Clinical factors associated with low serum progesterone levels on the day of frozen blastocyst transfer in hormonal replacement therapy cyclesC Maignien, M Bourdon, L Marcellin, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 23, 2013
Benefits of progestin contraception in non-allergic angioedemaC Saule, I Boccon-Gibod, O Fain, et al.
Human Reproduction (Oxford, England)|January 25, 2021
Adenomyosis of the inner and outer myometrium are associated with different clinical profilesM Bourdon, J Oliveira, L Marcellin, et al.
Pageof 7

Showing results (41-50 of 61) with videos related to

Sort By:
Pageof 7
European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)|March 1, 1993
Oral contraceptive use and risk of benign breast disease in a French case-control study of young womenI Charreau, G Plu-Bureau, A Bachelot, et al.
British Journal of Cancer|August 1, 1994
Progestogen use and decreased risk of breast cancer in a cohort study of premenopausal women with benign breast diseaseG Plu-Bureau, M G Lê, R Sitruk-Ware, et al.
Annales De Dermatologie Et De Venereologie|May 1, 2016
Pregnancy and contraception in systemic and cutaneous lupus erythematosusG Guettrot-Imbert, N Morel, V Le Guern, et al.
Gynecologie, Obstetrique, Fertilite & Senologie|May 3, 2017
[Learning the gynecological examination on low-fidelity simulation: Impact on the feelings of medical students]J Hugon-Rodin, C Sonigo, D Drummond, et al.
Thrombosis and Haemostasis|October 18, 1993
Haemostatic variables and menopausal status: influence of hormone replacement therapyP Y Scarabin, G Plu-Bureau, L Bara, et al.
Journal of Thrombosis and Haemostasis : JTH|August 31, 2004
Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptivesM Alhenc-Gelas, G Plu-Bureau, S Guillonneau, et al.
Thrombosis Research|May 9, 2001
Association of circulating cellular adhesion molecules with menopausal status and hormone replacement therapy. Time-dependent change in transdermal, but not oral estrogen usersE Oger, M Alhenc-Gelas, G Plu-Bureau, et al.
Human Reproduction (Oxford, England)|September 20, 2022
Clinical factors associated with low serum progesterone levels on the day of frozen blastocyst transfer in hormonal replacement therapy cyclesC Maignien, M Bourdon, L Marcellin, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|March 23, 2013
Benefits of progestin contraception in non-allergic angioedemaC Saule, I Boccon-Gibod, O Fain, et al.
Human Reproduction (Oxford, England)|January 25, 2021
Adenomyosis of the inner and outer myometrium are associated with different clinical profilesM Bourdon, J Oliveira, L Marcellin, et al.
Pageof 7